Clopidogrel and Ginkgo: Can You Take Them Together?

Moderate — Timing Mattersconflict
Learn about each ingredient:ClopidogrelGinkgo

Quick answer

Clopidogrel blocks the platelet P2Y12 ADP receptor, while ginkgo biloba inhibits platelet-activating factor through a separate pathway. A controlled healthy-volunteer study found no measurable added platelet inhibition, but case reports and an observational analysis link the combination to bleeding. The realistic concern is a modest, additive bleeding risk, most relevant in older patients and those also taking aspirin.

The safest default is to avoid ginkgo while taking clopidogrel, since both reduce platelet activity through different pathways and stacking them may raise bleeding risk, especially if you also take aspirin. If you and your prescriber decide it is worth trying, use a standardized extract, watch for bruising or bleeding, and stop ginkgo well before any planned surgery or procedure. Review this combination with your doctor or pharmacist.

What happens?

Clopidogrel and ginkgo both make platelets less able to clump, but they act through different pathways. Taken together, those antiplatelet effects can layer on top of each other.

1

Clopidogrel blockade

Clopidogrel (Plavix) is a prodrug that the liver activates. The active form irreversibly blocks the platelet P2Y12 ADP receptor, shutting down ADP-driven aggregation for the entire lifespan of each platelet.

2

Ginkgo pathway

Ginkgo leaf extract contains terpene lactones, especially ginkgolide B, which inhibit platelet-activating factor (PAF). This produces a mild antiplatelet effect through a mechanism distinct from P2Y12 blockade.

3

Overlapping effects

Because the two act on different parts of the clotting system, ginkgo's mild effect can stack onto clopidogrel's strong one. The net result can be a somewhat lower clotting capacity than clopidogrel alone.

A controlled randomized healthy-volunteer study found <strong>no measurable added platelet inhibition</strong>; the concern instead comes from case reports and a 2025 observational analysis pointing to a modest bleeding signal.

Why is this important?

People take clopidogrel for high-stakes reasons, so anything that nudges bleeding risk upward deserves a second look.

High-stakes protection

Clopidogrel is prescribed after a coronary stent, an ischemic stroke, or for peripheral arterial disease. Reliable antiplatelet protection is the whole point of the drug.

Stacked blood thinners

Many clopidogrel patients also take aspirin as dual antiplatelet therapy, which already raises bleeding risk. Adding ginkgo on top of two antiplatelet drugs is where the combined effect matters most.

Vulnerable patients

The realistic risk is a modest, additive bleeding risk concentrated in older, multi-medicated patients exposed for months or years, rather than a predictable serious bleed in everyone.

Easy to overlook

Ginkgo is sold over the counter and marketed for memory and circulation, so many people do not think of it as a drug and may not mention it at a medication review.

The evidence supports common-sense caution rather than a strong warning, but the safest default is to avoid the combination.

What should you do?

The practical fix is simple: separate the doses.

Avoid ginkgo on clopidogrel; if you combine them, do it deliberately with your prescriber

Best practical schedule

Before any change (starting or stopping ginkgo)
Talk to your doctor or pharmacist first. Ask whether ginkgo is appropriate given your other medications, especially if you also take aspirin or another blood thinner.
Every day while taking both
Watch for signs of bleeding and keep ginkgo on your medication list, mentioning it at every appointment. Do not increase the amount on your own.
Well before any procedure
Stop ginkgo ahead of any planned surgery, dental work, biopsy, colonoscopy, or epidural injection, confirming the exact stop timing with your prescriber.

Important reminders

  • Watch for unusual bruising, prolonged bleeding from small cuts, nosebleeds, and bleeding gums.
  • Keep ginkgo on your medication list and mention it at every appointment.
  • Do not increase the amount of ginkgo on your own.
  • Seek emergency care for severe sudden headache, vision changes, one-sided weakness or speech changes, black tarry stools, or coughing or vomiting blood.
  • Clear any decision to combine with your doctor or pharmacist, especially if you also take aspirin.

A stop window of roughly 7 to 10 days before a procedure is a common, practical precaution, but confirm the timing with your prescriber.

Which specific products are affected?

Many common Ginkgo products can affect this interaction.

Prescription antiplatelet drugs

Clopidogrel (Plavix)Prasugrel (Effient)Ticagrelor (Brilinta)Aspirin (often co-prescribed)Cilostazol

Standardized ginkgo extracts and branded products

EGb 761 standardized extractGBE 24/6 extractTeboninTanakanRokan

Other sources

  • Ginkgo teas and tinctures
  • Memory and brain-health formulas
  • Tinnitus and circulation blends
  • Proprietary nootropic blends where ginkgo is not highlighted on the front label

Read full ingredient lists, not just the marketing on the front of the bottle, and tell your pharmacist about every supplement you take.

The bottom line

Clopidogrel and ginkgo both reduce platelet clumping through different pathways, so their effects can add up. A controlled healthy-volunteer study found no added platelet inhibition, while case reports and a 2025 observational analysis suggest a modest bleeding signal, most relevant in older patients and those also on aspirin. The safest default is to avoid ginkgo while on clopidogrel; if you combine them, do so only with your prescriber's agreement.

Stop ginkgo well before any surgery or procedure, and seek care for serious bleeding signs.

What happens when you take clopidogrel with ginkgo?

Both clopidogrel and ginkgo make platelets less able to clump together, but they do it through different routes. When you take them together, those effects can add up.

  1. Clopidogrel switches off one platelet activation pathway. Clopidogrel (Plavix) is a prodrug that the liver converts into its active form. That active form irreversibly blocks the P2Y12 ADP receptor on platelets, shutting down ADP-driven platelet aggregation for the entire life of each platelet (about 7 to 10 days).
  2. Ginkgo dampens a separate platelet pathway. Ginkgo biloba leaf extract contains terpene lactones, especially ginkgolide B, which inhibit platelet-activating factor (PAF). This produces mild antiplatelet activity through a mechanism distinct from P2Y12 blockade.
  3. The two effects can overlap. Because the drugs act on different parts of the clotting system, ginkgo's mild effect can layer on top of clopidogrel's strong one. The net result is a somewhat lower clotting capacity than clopidogrel alone.

It is worth being honest about how strong this signal is. A controlled, randomized healthy-volunteer study did not detect any added platelet inhibition when ginkgo was combined with clopidogrel. The concern comes mainly from case reports of bleeding in people taking ginkgo and from a 2025 observational hospital-record analysis. That is a real but modest signal, not a dramatic one.

Why is this important?

People take clopidogrel for high-stakes reasons: after a coronary stent (where a clot in the stent can be life-threatening), after an ischemic stroke, or for peripheral arterial disease. The whole point of the drug is reliable antiplatelet protection, so adding anything that nudges bleeding risk upward deserves a second look.

Many clopidogrel patients also take aspirin as dual antiplatelet therapy, which already raises bleeding risk on its own. Layering ginkgo on top of two antiplatelet drugs is where the combined effect matters most.

There is a reason the evidence looks mixed. Short studies in young, healthy volunteers often show no interaction, while the people who actually report bleeding tend to be older, on more medications, and exposed for months or years rather than days. So the realistic risk is not "this combination predictably causes a serious bleed" — it is "this combination can modestly raise an already-present bleeding risk in vulnerable patients."

Ginkgo is sold over the counter and marketed for memory and circulation, so many people do not think of it as a drug and may not mention it during a medication review. That makes it easy to overlook.

What should you do?

The simplest, safest approach is to avoid ginkgo while on clopidogrel. Ginkgo's benefits for memory and tinnitus are modest and inconsistent in clinical trials, so for most people the small possible upside does not outweigh even a modest added bleeding risk. If you and your prescriber decide it is worth trying, do it deliberately and with a plan.

Before any change (starting or stopping ginkgo): Talk to your doctor or pharmacist first. Ask whether ginkgo is appropriate given your other medications, especially if you also take aspirin or another blood thinner. Agree on a standardized extract and a clear timeline to judge whether it is actually helping.

Every day while taking both: Watch for signs of bleeding — unusual bruising, prolonged bleeding from small cuts, nosebleeds, bleeding gums. Keep ginkgo on your medication list and mention it at every appointment. Do not increase the amount of ginkgo on your own.

After a change, or before a procedure: Stop ginkgo well ahead of any planned surgery, dental work, biopsy, colonoscopy, or epidural injection — a stop window of about 7 to 10 days is a common, practical precaution; confirm the timing with your prescriber. If any serious bleeding warning sign appears (severe sudden headache, vision changes, one-sided weakness or speech changes, black tarry stools, or coughing or vomiting blood), seek emergency care immediately.

Which specific products are affected?

On the prescription side, this applies to clopidogrel under any brand name, including Plavix, and at any dose your doctor prescribes. The same general bleeding considerations broadly apply to the other P2Y12 inhibitors prasugrel (Effient) and ticagrelor (Brilinta), to aspirin (often co-prescribed), and to other antiplatelet agents such as cilostazol.

On the supplement side, this covers standardized ginkgo leaf extracts (EGb 761, GBE 24/6) and branded products such as Tebonin, Tanakan, and Rokan, along with ginkgo teas and tinctures. Ginkgo also appears inside many memory, brain-health, tinnitus, and circulation formulas, and in proprietary nootropic blends where it may not be highlighted on the front label. Read full ingredient lists, not just the marketing on the front of the bottle.

The science behind it

The most directly relevant controlled study is a randomized crossover pharmacodynamic trial in healthy volunteers (Aruna and Naidu, British Journal of Clinical Pharmacology 2007; PMID 17010102), which examined ginkgo combined with clopidogrel and cilostazol. It did not find that ginkgo measurably increased clopidogrel's platelet inhibition. This is the main piece of reassuring evidence and a reason not to overstate the interaction.

The cautionary evidence comes from real-world data. A 2025 retrospective hospital-record analysis (Ngo et al., PLOS One; doi:10.1371/journal.pone.0321804) examined ginkgo drug interactions, bleeding risk, and coagulation profiles, and identified antiplatelet drugs including clopidogrel among those involved in ginkgo-related bleeding signals. Separately, case reports describe spontaneous bleeding in people taking ginkgo, including a report of spontaneous bilateral subdural hematomas associated with chronic ginkgo use (Rowin and Lewis, Neurology 1996; PMID 8649594).

Taken together, the evidence supports a moderate, common-sense caution rather than a strong warning: a controlled study shows no clear additive effect, while observational data and case reports suggest a modest bleeding signal that is most plausible in older, multi-medicated patients.

Frequently Asked Questions

Can I take ginkgo if I'm on clopidogrel?

The safest default is no. Both reduce platelet activity through different pathways, so they can add up. If you want to take ginkgo, clear it with your doctor or pharmacist first, especially if you also take aspirin.

How serious is this interaction?

It is considered moderate. A controlled healthy-volunteer study found no added platelet effect, but case reports and observational data point to a modest extra bleeding risk, mainly in older patients and those on more than one blood thinner.

What bleeding signs should I watch for?

Watch for unusual bruising, prolonged bleeding from cuts, nosebleeds, and bleeding gums. Treat as emergencies: severe sudden headache, vision changes, one-sided weakness or speech changes, black tarry stools, or coughing or vomiting blood.

Do I need to stop ginkgo before surgery?

Yes. Stop ginkgo well before any planned surgery, dental procedure, biopsy, colonoscopy, or epidural injection. A stop window of roughly a week to ten days is commonly used; confirm the exact timing with your prescriber.

Is ginkgo hidden in other products?

Often. Ginkgo turns up in memory, brain-health, tinnitus, and circulation blends and in nootropic supplements without being obvious on the label. Read the full ingredient list, and tell your pharmacist about every supplement you take.

Why do studies and real-world reports disagree?

Short studies in young, healthy people often miss interactions that appear in real patients, who are older, take more medications, and use ginkgo for months or years. That gap is why the recommendation is cautious rather than alarmed.

Key takeaways

  • Clopidogrel and ginkgo both reduce platelet clumping through different pathways, so their effects can add up.
  • A controlled healthy-volunteer study found no added platelet inhibition; the concern comes from case reports and a 2025 observational analysis — a modest, not dramatic, signal.
  • The risk matters most in older patients and those also taking aspirin or another blood thinner.
  • The safest default is to avoid ginkgo on clopidogrel; if you combine them, do so only with your prescriber's agreement.
  • Stop ginkgo well before any surgery or procedure, and seek care for serious bleeding signs.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Aspirin + Ginkgo

moderate

Ginkgo biloba can inhibit platelet-activating factor (PAF) and platelet aggregation, which may add to aspirin's irreversible inhibition of cyclooxygenase-1 and thromboxane A2. Observational data suggest a modest increase in minor bleeding events when the two are combined, and there are case reports of more serious bleeds in vulnerable patients, though a controlled trial found no measurable added effect on platelet function.

Warfarin + Ginkgo

moderate

Warfarin and ginkgo act on clotting through different pathways, raising a plausible but not firmly proven bleeding concern.

Rivaroxaban + Ginkgo

low

Rivaroxaban is a Factor Xa inhibitor and ginkgo has mild antiplatelet activity, so combining them was theorized to add to bleeding risk. However, a controlled trial in healthy subjects found standardized EGb 761 ginkgo extract did not change rivaroxaban's pharmacokinetics, anti-Factor Xa activity, or coagulation parameters, and caused no bleeding-related adverse events.

Warfarin + Dong Quai

high

Dong quai (Angelica sinensis) contains coumarin-family compounds (ferulic acid, osthole) and has antiplatelet activity in laboratory studies. A published case report described a previously stable warfarin patient whose INR climbed well above her target range within weeks of adding dong quai, then returned to normal after she stopped it. The signal rests on a single human case plus animal data, so it is taken seriously but is not extensively documented.

Warfarin + Feverfew

low

Feverfew (Tanacetum parthenium) inhibits platelet aggregation in laboratory studies via its parthenolide sesquiterpene lactones, which creates a theoretical, additive bleeding concern alongside warfarin. The evidence is bench/in-vitro only: systematic reviews classify feverfew's anticoagulant signal as low-level laboratory evidence, and there are no published human case reports of bleeding when feverfew is combined with warfarin. The cautious, mechanism-based approach is to avoid concentrated feverfew supplements while on warfarin and to disclose use to the clinician managing anticoagulation.

Aspirin + Fish Oil

low

Omega-3 fatty acids in fish oil mildly reduce platelet aggregation, which in theory adds to aspirin's antiplatelet effect. In practice, clinical studies have not found a clinically significant increase in major bleeding when standard fish oil is combined with aspirin.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free